Cargando…
Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors
[Image: see text] Finding antivirals for SARS-CoV-2 is still a major challenge, and many computational and experimental approaches have been employed to find a solution to this problem. While the global vaccination campaigns are the primary driver of controlling the current pandemic, orally bioavail...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380819/ https://www.ncbi.nlm.nih.gov/pubmed/35983371 http://dx.doi.org/10.1021/acsomega.2c01707 |
_version_ | 1784768950270164992 |
---|---|
author | Puhl, Ana C. Mottin, Melina Sacramento, Carolina Q. Tavella, Tatyana Almeida Dias, Gabriel Gonçalves Fintelman-Rodrigues, Natalia Temerozo, Jairo R. Dias, Suelen S. G. Ramos, Paulo Ricardo Pimenta da Silva Merten, Eric M. Pearce, Kenneth H. Costa, Fabio Trindade Maranhão Premkumar, Lakshmanane Souza, Thiago Moreno L. Andrade, Carolina Horta Ekins, Sean |
author_facet | Puhl, Ana C. Mottin, Melina Sacramento, Carolina Q. Tavella, Tatyana Almeida Dias, Gabriel Gonçalves Fintelman-Rodrigues, Natalia Temerozo, Jairo R. Dias, Suelen S. G. Ramos, Paulo Ricardo Pimenta da Silva Merten, Eric M. Pearce, Kenneth H. Costa, Fabio Trindade Maranhão Premkumar, Lakshmanane Souza, Thiago Moreno L. Andrade, Carolina Horta Ekins, Sean |
author_sort | Puhl, Ana C. |
collection | PubMed |
description | [Image: see text] Finding antivirals for SARS-CoV-2 is still a major challenge, and many computational and experimental approaches have been employed to find a solution to this problem. While the global vaccination campaigns are the primary driver of controlling the current pandemic, orally bioavailable small-molecule drugs and biologics are critical to overcome this global issue. Improved therapeutics and prophylactics are required to treat people with circulating and emerging new variants, addressing severe infection, and people with underlying or immunocompromised conditions. The SARS-CoV-2 envelope spike is a challenging target for viral entry inhibitors. Pindolol presented a good docking score in a previous virtual screening using computational docking calculations after screening a Food and Drug Administration (FDA)-approved drug library of 2400 molecules as potential candidates to block the SARS-CoV-2 spike protein interaction with the angiotensin-converting enzyme 2 (ACE-2). Here, we expanded the computational evaluation to identify five beta-blockers against SARS-CoV-2 using several techniques, such as microscale thermophoresis, NanoDSF, and in vitro assays in different cell lines. These data identified carvedilol with a K(d) of 364 ± 22 nM for the SARS-CoV-2 spike and in vitro activity (EC(50) of 7.57 μM, CC(50) of 18.07 μM) against SARS-CoV-2 in Calu-3 cells. We have shown how we can apply multiple computational and experimental approaches to find molecules that can be further optimized to improve anti-SARS-CoV-2 activity. |
format | Online Article Text |
id | pubmed-9380819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-93808192022-08-16 Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors Puhl, Ana C. Mottin, Melina Sacramento, Carolina Q. Tavella, Tatyana Almeida Dias, Gabriel Gonçalves Fintelman-Rodrigues, Natalia Temerozo, Jairo R. Dias, Suelen S. G. Ramos, Paulo Ricardo Pimenta da Silva Merten, Eric M. Pearce, Kenneth H. Costa, Fabio Trindade Maranhão Premkumar, Lakshmanane Souza, Thiago Moreno L. Andrade, Carolina Horta Ekins, Sean ACS Omega [Image: see text] Finding antivirals for SARS-CoV-2 is still a major challenge, and many computational and experimental approaches have been employed to find a solution to this problem. While the global vaccination campaigns are the primary driver of controlling the current pandemic, orally bioavailable small-molecule drugs and biologics are critical to overcome this global issue. Improved therapeutics and prophylactics are required to treat people with circulating and emerging new variants, addressing severe infection, and people with underlying or immunocompromised conditions. The SARS-CoV-2 envelope spike is a challenging target for viral entry inhibitors. Pindolol presented a good docking score in a previous virtual screening using computational docking calculations after screening a Food and Drug Administration (FDA)-approved drug library of 2400 molecules as potential candidates to block the SARS-CoV-2 spike protein interaction with the angiotensin-converting enzyme 2 (ACE-2). Here, we expanded the computational evaluation to identify five beta-blockers against SARS-CoV-2 using several techniques, such as microscale thermophoresis, NanoDSF, and in vitro assays in different cell lines. These data identified carvedilol with a K(d) of 364 ± 22 nM for the SARS-CoV-2 spike and in vitro activity (EC(50) of 7.57 μM, CC(50) of 18.07 μM) against SARS-CoV-2 in Calu-3 cells. We have shown how we can apply multiple computational and experimental approaches to find molecules that can be further optimized to improve anti-SARS-CoV-2 activity. American Chemical Society 2022-08-08 /pmc/articles/PMC9380819/ /pubmed/35983371 http://dx.doi.org/10.1021/acsomega.2c01707 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Puhl, Ana C. Mottin, Melina Sacramento, Carolina Q. Tavella, Tatyana Almeida Dias, Gabriel Gonçalves Fintelman-Rodrigues, Natalia Temerozo, Jairo R. Dias, Suelen S. G. Ramos, Paulo Ricardo Pimenta da Silva Merten, Eric M. Pearce, Kenneth H. Costa, Fabio Trindade Maranhão Premkumar, Lakshmanane Souza, Thiago Moreno L. Andrade, Carolina Horta Ekins, Sean Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors |
title | Computational and
Experimental Approaches Identify
Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors |
title_full | Computational and
Experimental Approaches Identify
Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors |
title_fullStr | Computational and
Experimental Approaches Identify
Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors |
title_full_unstemmed | Computational and
Experimental Approaches Identify
Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors |
title_short | Computational and
Experimental Approaches Identify
Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors |
title_sort | computational and
experimental approaches identify
beta-blockers as potential sars-cov-2 spike inhibitors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380819/ https://www.ncbi.nlm.nih.gov/pubmed/35983371 http://dx.doi.org/10.1021/acsomega.2c01707 |
work_keys_str_mv | AT puhlanac computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT mottinmelina computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT sacramentocarolinaq computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT tavellatatyanaalmeida computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT diasgabrielgoncalves computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT fintelmanrodriguesnatalia computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT temerozojairor computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT diassuelensg computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT ramospauloricardopimentadasilva computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT mertenericm computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT pearcekennethh computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT costafabiotrindademaranhao computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT premkumarlakshmanane computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT souzathiagomorenol computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT andradecarolinahorta computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors AT ekinssean computationalandexperimentalapproachesidentifybetablockersaspotentialsarscov2spikeinhibitors |